Lifevantage Corporation (NASDAQ:LFVN - Get Free Report)'s stock price passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $6.07 and traded as high as $6.40. Lifevantage shares last traded at $6.24, with a volume of 36,150 shares changing hands.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the stock. Lake Street Capital upped their target price on shares of Lifevantage from $5.00 to $6.00 and gave the stock a "hold" rating in a report on Friday, August 28th. Weiss Ratings reissued a "hold (c)" rating on shares of Lifevantage in a report on Friday, August 21st. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $5.50.
Check Out Our Latest Stock Report on Lifevantage
Lifevantage Stock Performance
The company has a 50-day simple moving average of $6.41 and a 200-day simple moving average of $6.07. The stock has a market cap of $78.56 million, a P/E ratio of 15.60 and a beta of 0.68.
Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its earnings results on Thursday, August 27th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Lifevantage had a return on equity of 21.56% and a net margin of 2.78%.The business had revenue of $42.38 million for the quarter, compared to the consensus estimate of $44.00 million. As a group, sell-side analysts expect that Lifevantage Corporation will post 0.39 earnings per share for the current fiscal year.
Lifevantage Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.20 dividend on an annualized basis and a yield of 3.2%. Lifevantage's dividend payout ratio is currently 50.00%.
Insiders Place Their Bets
In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of the business's stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $6.18, for a total value of $55,008.18. Following the completion of the transaction, the insider directly owned 120,162 shares of the company's stock, valued at approximately $742,601.16. The trade was a 6.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 13.58% of the company's stock.
Institutional Trading of Lifevantage
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Engineers Gate Manager LP lifted its holdings in Lifevantage by 109.7% in the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company's stock valued at $169,000 after buying an additional 14,131 shares during the period. Bank of New York Mellon Corp acquired a new stake in Lifevantage during the 2nd quarter worth $78,000. Bank of America Corp DE raised its position in shares of Lifevantage by 24.3% during the first quarter. Bank of America Corp DE now owns 23,445 shares of the company's stock worth $101,000 after purchasing an additional 4,586 shares during the period. Hsbc Holdings PLC bought a new position in Lifevantage in the first quarter valued at approximately $51,000. Finally, DGS Capital Management LLC bought a new stake in Lifevantage in the 1st quarter valued at approximately $44,000. Institutional investors and hedge funds own 35.32% of the company's stock.
Lifevantage Company Profile
(
Get Free Report)
LifeVantage Corporation is a health and wellness company that develops, markets and sells dietary supplements, skincare products and other wellness offerings. Its products are designed to support areas such as cellular health, antioxidant defenses, healthy aging, beauty and overall well-being.
The company's product portfolio has included Protandim, a line of supplements centered on the body's antioxidant response, as well as LifeVantage skincare and wellness products. LifeVantage sells primarily through a direct-selling model that combines independent distributors, known as consultants, with digital and e-commerce channels.
Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets, including Canada, Japan, Australia, Mexico, Hong Kong and Taiwan.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lifevantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.
While Lifevantage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.